Jeffrey Marbach, MD
Cardiovascular Disease · Portland, ORNPI 1215290895
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (45.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 64.7% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $14,478, more than ten times the $16 reported in 2021. Among cardiovascular disease clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $183.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- Abiomed$3K
- Procyrion, Inc.$2K
- Boston Scientific$1K
- Shockwave Medical, Inc$356
- Edwards Lifesciences$153
- plus $219 from 3 others
Across 7 payments — averaging $7337.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Procyrion, Inc.$38K
- Boston Scientific$13K
What the payments were for
- Consulting fees$2,78815%
- Speaking & faculty fees$8,55045%
- Travel & lodging$3,26917%
- Food & beverage$4,17622%
- Education$1001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 46 | $12,223 |
| Abiomed | 32 | $2,749 |
| Procyrion, Inc. | 2 | $2,180 |
| Boston Scientific | 9 | $1,002 |
| Shockwave Medical, Inc | 9 | $356 |
| Edwards Lifesciences | 2 | $153 |
| Abbott | 1 | $103 |
| Astellas Pharma US Inc | 1 | $100 |
| Asahi Intecc USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,882 in reported general payments places this provider in the 90th percentile of 198 cardiovascular disease providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 98 | $1,117 |
| Pantoprazole Sodium | 12 | $142 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Portland
- Firas ZahrPortland$810K
- Scott ChadderdonPortland$282K
- Ahmad MasriPortland$227K
- Stephen HeitnerPortland$105K
- Abhushan PoudyalPortland$54K
- Douglas DawleyPortland$45K
- Kishor KhanalPortland$39K
- Laith AlkukhunPortland$16K
- Tyler GluckmanPortland$15K
- Sylvia Marie BisoPortland$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.